NEW YORK--(BUSINESS WIRE)--Acuamark Diagnostics, Inc., a biotechnology company that focuses on developing accurate and cost-effective blood-based screening tests for the early detection of cancer, today announced the addition of Mr. Haywood D. Cochrane to its Board of Directors. Mr. Cochrane will transition from his current position as member of Acuamark Diagnostics’ Advisory Board.
Mr. Cochrane is a seasoned industry executive with over 30 years of healthcare, laboratory and diagnostics industry experience in executive and senior management positions. Currently, Mr. Cochrane serves as a Director of Corium, Inc., and is Vice Chair of the Board of Trustees at the University Of North Carolina At Chapel Hill.
